Minnesota lawmakers are once again calling on insurance companies to cover anti-obesity medications like Ozempic and Wegovy ...

Novo Nordisk NVO announced that it is launching a new direct-to-patient online pharmacy called NovoCare, which will offer its ...

A new global study published in The Lancet journal is sounding the alarm on worldwide obesity rates. The Lancet predicts that by 2050, over 50% of adults will be overweight, with 1 in 3 young adults ...

You know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid ...

Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...

Elsewhere in the obesity space — Amgen has initiated Phase 3 trials of its obesity drug MariTide, one in overweight and obese people without diabetes and another one for people with diabetes.

Studies suggest types of fasting can lead to moderate weight loss and other health benefits in overweight and obese people, ...

Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much worse it could get. A team of researchers found that in 2021, one billion men ...

One effective action involves addressing obesity, a major driver of chronic disease and health care costs. Obesity is an epidemic, and now we have safe options to help individuals who may need it in ...

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...

Administration of semaglutide before metabolic and bariatric surgery does not confer benefits for overall weight loss, ...

Not necessarily — but it’s complicated. For years, body size was considered a barrier to most sports, but today that’s ...